What is the current Prefilled Syringes market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Prefilled Syringes market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Prefilled Syringes market?

Increasing demand for self-administered drugs drives the market.

What are the major challenges facing the Prefilled Syringes market?

High development costs and stringent regulations are major challenges.

Which regions are leading the Prefilled Syringes market?

North America and Europe are the leading regions.

Who are the top companies in the Prefilled Syringes market?

Top companies include Becton Dickinson and Company and Gerresheimer.

What future opportunities exist in the Prefilled Syringes market?

Emerging markets and innovative technologies offer future opportunities.

How does technology impact the Prefilled Syringes market?

Advances in technology improve safety and efficacy.

What is the current regulatory landscape for Prefilled Syringes?

Regulations vary by region, with strict guidelines in the US and EU.

What is the future outlook for the Prefilled Syringes market?

The future outlook is positive, driven by increasing demand.

Prefilled Syringes Market 2026: Primary Research + Expert Analysis

Prefilled Syringes by Application (Vaccine, Antithrombotic Drugs, Bioengineered Drugs, Other (Beauty, Etc.)), by Types (Glass Prefilled Syringes, Plastic Prefilled Syringes), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 139

Forecast Period: 2026 - 2033

Market Size: $6540 million

CAGR: 2.6%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 139

Forecast Period: 2026 - 2033

Market Size: $6540 million

CAGR: 2.6%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Prefilled Syringes Market Size | CAGR 2.6% Forecast 2033

Prefilled Syringes Market 2026: Primary Research + Expert Analysis

🏭 Healthcare🌍 Global

Pages: 139

Forecast Period: 2026 - 2033

Market Size: $6540 million

CAGR: 2.6%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 139

Forecast Period: 2026 - 2033

Market Size: $6540 million

CAGR: 2.6%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Prefilled Syringes Market Overview

The Prefilled Syringes market refers to the global industry involved in the design, development, and distribution of prefilled syringes, which are medical devices used to administer drugs. As a crucial segment of the healthcare industry, the Prefilled Syringes market size is estimated to be around $7.9 billion in 2025. The growth outlook for the Prefilled Syringes market forecast is promising, driven by factors such as increasing demand for injectable drugs, advancements in medical technology, and the need for convenient and safe drug delivery systems. The market forecast suggests a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033, indicating a positive industry expansion. Primary drivers of this growth include technology shifts towards more efficient and patient-friendly devices, regulations promoting the use of prefilled syringes for safety and efficacy, and changes in consumer behavior favoring convenient healthcare solutions.

Loading chart…

Key forces shaping the Prefilled Syringes industry include technological advancements in syringe design and manufacturing, regulatory frameworks that promote the use of prefilled syringes for their safety and efficacy, and competitive intensity among market players. The largest region for the Prefilled Syringes market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare spending and a growing demand for injectable therapies. As the market continues to evolve, understanding these dynamics will be crucial for strategic planners and business development teams looking to capitalize on emerging opportunities in the Prefilled Syringes market.

Report Overview

Report Attribute	Details
Market size value in 2025	6.54 billion
Revenue forecast in 2033	11.41 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Gerresheimer; Nipro Corporation; Schott; Stevanato; Baxter BioPharma Solution; Rovi CM; Terumo; Vetter; Catalent; Taisei Kako; Roselabs Group; West Pharma; Weigao Group; Shandong Zibo Minkang Pharmaceutical Packaging Co.,Ltd.; Shandong Pharmaceutical Glass co.,LTD; Ningbo Zhengli Pharmaceutical Packaging Co.,Ltd; Shandong Ujoin Medical Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Prefilled Syringes market is poised for significant growth, driven by a combination of technological advancements, regulatory requirements, and shifting demand patterns. Understanding the dynamics of this market is crucial for stakeholders to navigate its complexities and capitalize on emerging opportunities.

Growth Drivers2 items

Advancements in Prefilled Syringes technology, such as improved safety features and enhanced drug delivery systems, are anticipated to drive the Prefilled Syringes market size and contribute to its growth forecast.

Increasing demand for convenient, user-friendly drug delivery systems, particularly among patients with chronic conditions, is expected to propel the adoption of Prefilled Syringes and subsequently influence the Prefilled Syringes market.

Restraints2 items

Stringent regulatory requirements and high manufacturing costs associated with Prefilled Syringes may hinder the growth of the Prefilled Syringes market, as companies may struggle to maintain profitability while adhering to strict quality standards.

Competition from alternative drug delivery systems, such as injectable devices and oral formulations, may also restrain the growth of the Prefilled Syringes market, as patients and healthcare providers may prefer these options due to their perceived benefits or lower costs.

Opportunities2 items

Emerging markets, particularly in Asia-Pacific and Latin America, present significant opportunities for the Prefilled Syringes market due to their large and growing patient populations, increasing healthcare expenditures, and rising demand for advanced drug delivery systems.

Partnerships and collaborations between Prefilled Syringes manufacturers and pharmaceutical companies can facilitate the development of new, innovative products, enhancing the growth forecast of the Prefilled Syringes market and expanding its reach into new therapeutic areas.

Challenges2 items

Ensuring the safety and efficacy of Prefilled Syringes remains a significant challenge, as these products must undergo rigorous testing and meet stringent regulatory standards to minimize the risk of adverse events and maintain patient trust.

Managing the supply chain and maintaining a stable, reliable source of high-quality components and materials is crucial for Prefilled Syringes manufacturers, as disruptions or shortages can impact production capacity and ultimately affect the Prefilled Syringes market size.

Market Segmentation

Loading chart…

The Application segment of the Prefilled Syringes market is a critical component of the overall market taxonomy. This segment is divided into subcategories such as vaccines, insulin, and other therapies. Each of these subcategories contributes to the overall Prefilled Syringes market size, with vaccines being a significant contributor due to the increasing demand for prefilled syringes in vaccine administration. Understanding the Prefilled Syringes segmentation by application is crucial for stakeholders to identify growth opportunities and make informed decisions.

The Types segment of the Prefilled Syringes market is another essential aspect of the market taxonomy. This segment includes subtypes such as glass prefilled syringes and plastic prefilled syringes. Glass prefilled syringes are the most commonly used type due to their compatibility with a wide range of drugs. The Types segment contributes significantly to the overall market size, with the demand for glass prefilled syringes driving the growth of the Prefilled Syringes market. Analyzing the market taxonomy, including the Prefilled Syringes segmentation, helps stakeholders to better understand the market dynamics and trends.

Prefilled Syringes Segmentation Breakdown8 items

Application

Vaccine

Antithrombotic Drugs

Bioengineered Drugs

Other (Beauty, Etc.)

Types

Glass Prefilled Syringes

Plastic Prefilled Syringes

Regional Insights

Loading chart…

The Prefilled Syringes market growth is expected to vary across regions, driven by factors such as adoption, policies, investments, demographics, infrastructure, and ecosystem maturity. North America is the largest region, accounting for approximately 40% of the global market, driven by high adoption rates, favorable policies, and significant investments in the healthcare sector. The region's mature infrastructure and ecosystem also support the growth of the Prefilled Syringes market.

Asia Pacific is the fastest-growing region, with a regional forecast indicating a significant increase in demand for Prefilled Syringes. Key drivers for this region include growing demographics, increasing investments in healthcare infrastructure, and rising adoption of Prefilled Syringes. Europe, Latin America, and Middle East & Africa also contribute to the global Prefilled Syringes market, with key drivers including government policies, rising demand for self-administration devices, and expanding distribution networks.

Key Drivers by Region5 items

North America: high adoption rates, favorable policies, significant investments

Asia Pacific: growing demographics, increasing investments in healthcare infrastructure, rising adoption

Europe: government policies, rising demand for self-administration devices

Latin America: expanding distribution networks, increasing healthcare expenditure

Middle East & Africa: rising demand for Prefilled Syringes, growing healthcare infrastructure

Competitive Landscape

The Prefilled Syringes market is moderately consolidated, driven by a mix of global players and local companies. The Prefilled Syringes competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies compete on pricing and distribution.

Common strategies among key players include M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting their strategies to address these challenges and maintain their market position.

BD: regional expansion

Gerresheimer: innovation pipeline

Nipro Corporation: local manufacturing

Schott: premium pricing

Stevanato: vertical integration

Baxter BioPharma Solution: OEM tie-ups

Key Prefilled Syringes Companies18 items

Gerresheimer

Nipro Corporation

Schott

Stevanato

Baxter BioPharma Solution

Rovi CM

Terumo

Vetter

Catalent

Taisei Kako

Roselabs Group

West Pharma

Weigao Group

Shandong Zibo Minkang Pharmaceutical Packaging Co.,Ltd.

Shandong Pharmaceutical Glass co.,LTD

Ningbo Zhengli Pharmaceutical Packaging Co.,Ltd

Shandong Ujoin Medical Technology

Market Ecosystem

The Prefilled Syringes ecosystem encompasses a complex network of participants, spanning upstream, midstream, and downstream activities. This ecosystem is characterized by the interplay between technology providers, suppliers, integrators, channels, and end users, all of which contribute to the creation and capture of value. The Prefilled Syringes ecosystem is shaped by the flow of materials, technologies, and services, from raw material suppliers to end users, with each participant playing a distinct role in the value chain analysis.

Raw material suppliers — provide critical components

OEMs / manufacturers — produce Prefilled Syringes

Technology providers — develop innovative solutions

System integrators / EPCs — assemble and integrate systems

Distributors / channel partners — deliver products to market

Regulators/standards bodies — establish and enforce standards

End users / buyers — purchase and utilize Prefilled Syringes

The flow of value in the Prefilled Syringes ecosystem is influenced by various control points, including regulatory approvals, standards, and partnerships between participants. Dependency risks, such as input constraints and approval timelines, can impact the ecosystem's efficiency. Switching costs and interoperability requirements also affect the dynamics between participants. Furthermore, regional differences in the Prefilled Syringes ecosystem can lead to variations in adoption and market development, underscoring the need for a nuanced understanding of this complex landscape.

Recent Industry Insights

The Prefilled Syringes industry trends have witnessed significant developments over the last 12-18 months, driven by advancements in technology and evolving consumer needs. Recent partnerships, such as collaborations between pharmaceutical companies and contract manufacturers, have focused on improving supply chain efficiency and reducing production costs. Additionally, there have been notable mergers and acquisitions, with major players expanding their product portfolios and strengthening their market presence.

Furthermore, the industry has seen several product launches, including innovative prefilled syringe systems with enhanced safety features and improved user experience. Regulatory changes, such as updated guidelines for prefilled syringe manufacturing, have also had a profound impact on the industry. As a result, companies are adapting to these shifts by investing in research and development, and exploring new markets and applications for prefilled syringes.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Prefilled Syringes market outlook. The market attractiveness is high due to increasing demand for convenient and safe drug delivery systems. The competitive intensity is moderate, with key players focusing on innovation and partnerships to gain market share. The long-term outlook is positive, driven by growing adoption in various therapeutic areas.

The innovation landscape is evolving, with advancements in syringe design and materials. The demand–supply balance is expected to be stable, with manufacturers investing in capacity expansion. However, key risk factors such as regulatory changes and supply chain disruptions need to be monitored. Overall, the Prefilled Syringes market is poised for growth, driven by its attractiveness and positive long-term outlook.

12 items

1. Executive Summary

2. Prefilled Syringes Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Prefilled Syringes Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Prefilled Syringes Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Prefilled Syringes Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Prefilled Syringes Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Prefilled Syringes Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Prefilled Syringes Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Prefilled Syringes Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Prefilled Syringes Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Prefilled Syringes Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Prefilled Syringes Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Prefilled Syringes Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Prefilled Syringes Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Prefilled Syringes Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Prefilled Syringes Market Competition by Key Manufacturers

9.1. Global Prefilled Syringes Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Prefilled Syringes: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. BD

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Gerresheimer

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Nipro Corporation

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Schott

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Stevanato

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Baxter BioPharma Solution

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Rovi CM

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Terumo

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Vetter

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Catalent

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Taisei Kako

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Roselabs Group

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. West Pharma

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Weigao Group

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Shandong Zibo Minkang Pharmaceutical Packaging Co.,Ltd.

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Shandong Pharmaceutical Glass co.,LTD

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Ningbo Zhengli Pharmaceutical Packaging Co.,Ltd

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Shandong Ujoin Medical Technology

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Prefilled Syringes Market

Figure 4: Global Prefilled Syringes Market: Drivers

Figure 5: Global Prefilled Syringes Market: Challenges

Figure 6: Global Prefilled Syringes Market: Trends

Figure 7: Global Prefilled Syringes Market: Opportunity

Figure 8: Global Prefilled Syringes Market: Restraint

Figure 9: Global Prefilled Syringes Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Prefilled Syringes Market Value (USD Million) By Region

Figure 19: Global Prefilled Syringes Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Prefilled Syringes Market Value (USD Million) By Region

Figure 27: Global Prefilled Syringes Market Share (%) By: Regions (2032)

Figure 28: Global Prefilled Syringes Market Volume (K) By Region

Figure 29: Global Prefilled Syringes Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Prefilled Syringes Market Value (USD Million) By Region

Figure 37: Global Prefilled Syringes Market Share (%) By: Regions (2032)

Figure 38: Global Prefilled Syringes Market Volume (K) By Region

Figure 39: Global Prefilled Syringes Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

131 items

Table 1: Market Segmentation Analysis

Table 2: Global Prefilled Syringes Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Prefilled Syringes Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Prefilled Syringes Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Prefilled Syringes Market Value (USD Million) By Region

Table 14: Global Prefilled Syringes Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Prefilled Syringes Market Volume (K) By Region

Table 31: Global Prefilled Syringes Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Prefilled Syringes Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Prefilled Syringes Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Prefilled Syringes Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: BD Basic Information And Sales Area

Table 52: BD. Products Portfolio

Table 53: Gerresheimer Basic Information And Sales Area

Table 54: Gerresheimer. Products Portfolio

Table 55: Nipro Corporation Basic Information And Sales Area

Table 56: Nipro Corporation. Products Portfolio

Table 57: Schott Basic Information And Sales Area

Table 58: Schott. Products Portfolio

Table 59: Stevanato Basic Information And Sales Area

Table 60: Stevanato. Products Portfolio

Table 61: Baxter BioPharma Solution Basic Information And Sales Area

Table 62: Baxter BioPharma Solution. Products Portfolio

Table 63: Rovi CM Basic Information And Sales Area

Table 64: Rovi CM. Products Portfolio

Table 65: Terumo Basic Information And Sales Area

Table 66: Terumo. Products Portfolio

Table 67: Vetter Basic Information And Sales Area

Table 68: Vetter. Products Portfolio

Table 69: Catalent Basic Information And Sales Area

Table 70: Catalent. Products Portfolio

Table 71: Taisei Kako Basic Information And Sales Area

Table 72: Taisei Kako. Products Portfolio

Table 73: Roselabs Group Basic Information And Sales Area

Table 74: Roselabs Group. Products Portfolio

Table 75: West Pharma Basic Information And Sales Area

Table 76: West Pharma. Products Portfolio

Table 77: Weigao Group Basic Information And Sales Area

Table 78: Weigao Group. Products Portfolio

Table 79: Shandong Zibo Minkang Pharmaceutical Packaging Co.,Ltd. Basic Information And Sales Area

Table 80: Shandong Zibo Minkang Pharmaceutical Packaging Co.,Ltd.. Products Portfolio

Table 81: Shandong Pharmaceutical Glass co.,LTD Basic Information And Sales Area

Table 82: Shandong Pharmaceutical Glass co.,LTD. Products Portfolio

Table 83: Ningbo Zhengli Pharmaceutical Packaging Co.,Ltd Basic Information And Sales Area

Table 84: Ningbo Zhengli Pharmaceutical Packaging Co.,Ltd. Products Portfolio

Table 85: Shandong Ujoin Medical Technology Basic Information And Sales Area

Table 86: Shandong Ujoin Medical Technology. Products Portfolio

Table 87: Global Market Value (USD Million) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Value (USD Million) (2025-2032) By Types

Table 90: Global Market Share (%) By Types (2032)

Table 91: Global Market Volume (K) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Market Volume (K) (2025-2032) By Types

Table 94: Global Market Share (%) By Types (2032)

Table 95: Global Prefilled Syringes Market Value (USD Million) By Region

Table 96: Global Prefilled Syringes Market Share (%) By Region (2025-2032)

Table 97: North America Market Value (USD Million) (2025-2032) By Country

Table 98: North America Market Value (USD Million) (2025-2032) By Application

Table 99: North America Market Value (USD Million) (2025-2032) By Types

Table 100: Europe Market Value (USD Million) (2025-2032) By Country

Table 101: Europe Market Value (USD Million) (2025-2032) By Application

Table 102: Europe Market Value (USD Million) (2025-2032) By Types

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 104: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 106: South America Market Value (USD Million) (2025-2032) By Country

Table 107: South America Market Value (USD Million) (2025-2032) By Application

Table 108: South America Market Value (USD Million) (2025-2032) By Types

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 110: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 112: Global Prefilled Syringes Market Volume (K) By Region

Table 113: Global Prefilled Syringes Market Share (%) By Region (2025-2032)

Table 114: North America Market Volume (K) (2025-2032) By Country

Table 115: North America Market Volume (K) (2025-2032) By Application

Table 116: North America Market Volume (K) (2025-2032) By Types

Table 117: Europe Market Volume (K) (2025-2032) By Country

Table 118: Europe Market Volume (K) (2025-2032) By Application

Table 119: Europe Market Volume (K) (2025-2032) By Types

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 121: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 123: South America Market Volume (K) (2025-2032) By Country

Table 124: South America Market Volume (K) (2025-2032) By Application

Table 125: South America Market Volume (K) (2025-2032) By Types

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 127: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 129: Research Programs/Design For This Report

Table 130: Key Data Information From Secondary Sources

Table 131: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Prefilled Syringes Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	6.54 billion
Revenue forecast in 2033	11.41 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Gerresheimer; Nipro Corporation; Schott; Stevanato; Baxter BioPharma Solution; Rovi CM; Terumo; Vetter; Catalent; Taisei Kako; Roselabs Group; West Pharma; Weigao Group; Shandong Zibo Minkang Pharmaceutical Packaging Co.,Ltd.; Shandong Pharmaceutical Glass co.,LTD; Ningbo Zhengli Pharmaceutical Packaging Co.,Ltd; Shandong Ujoin Medical Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options